People are different: Tyrosine's modulating effect on cognitive control in healthy humans may depend on individual differences related to dopamine function

Frontiers in Psychology

Volumn 5, Issue OCT, 2014, Pages

  Jongkees, Bryant J ^a   Hommel, Bernhard ^a   Colzato, Lorenza S ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Cognition; Dopamine; Genetics; Individual differences; Tyrosine

Indexed keywords

EID: 84907693611     PISSN: None     EISSN: 16641078     Source Type: Journal    
DOI: 10.3389/fpsyg.2014.01101     Document Type: Note

References (61)

1. Bäckman, L., Ginovart, N., Dixon, R. A., Wahlin, T. B., Wahlin, A., Halldin, C., et al. (2000). Age-related cognitive deficits mediated by changes in the striatal dopamine system. Am. J. Psychiatry 157, 635-637. doi: 10.1176/appi.ajp.157.4.635
2. Bäckman, L., Nyberg, L., Lindenberger, U., Li, S.-C., and Farde, L. (2006). The correlative triad among aging, dopamine, and cognition: current status and future prospects. Neurosci. Biobehav. Rev. 30, 791-807. doi: 10.1016/j.neubiorev.2006.06.005
3. Baumeister, R. F., Bratslavsky, E., Muraven, M., and Tice, D. M. (1998). Ego depletion: is the active self a limited resource? J. Pers.Soc. Psychol. 74, 1252-1265. doi: 10.1037/0022-3514.74.5.1252
4. Bodis-Wollner, I., and Tzelepi, A. (1998). The push-pull action of dopamine on spatial tuning of the monkey retina: the effects of dopaminergic deficiency and selective D1 and D2 receptors ligands on the pattern electroretinogram. Vision Res. 38, 1479-1487. doi: 10.1016/S0042-6989(98)00028-5
5. Buu, N. T., and Kuchel, O. (1979). The direct conversion of dopamine 3-0-sulfate to norepinephrine by dopamine-ß-hydroxylase. Life Sci. 24, 783-790. doi: 10.1016/0024-3205(79)90361-8
6. Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., et al. (2004). Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am. J. Hum. Genet. 75, 807-821. doi: 10.1086/425589
7. Colzato, L. S., Jongkees, B. J., Sellaro, R., and Hommel, B. (2013a). Working memory reloaded: tyrosine repletes updating in the N-back task. Front. Behav. Neurosci. 7:200. doi: 10.3389/fnbeh.2013.00200
8. Colzato, L. S., Jongkees, B. J., van den Wildenberg, W. P. M., and Hommel, B. (2014a). Eating to stop: tyrosine supplementation enhances inhibitory control but not response execution. Neuropsychologia 62, 398-402. doi: 10.1016/j.neuropsychologia.2013.12.027
9. Colzato, L. S., Sellaro, R., Hulka, L. M., Quednow, B. B., and Hommel, B. (2014b). Cognitive control predicted by color vision, and vice versa. Neuropsychologia 62, 55-59. doi: 10.1016/j.neuropsychologia.2014.07.010
10. Colzato, L. S., Slagter, H. A., Spapé, M. A., and Hommel, B. (2008a). Blinks of the eye predict blinks of the mind. Neuropsychologia 46, 3179-3183. doi: 10.1016/j.neuropsychologia.2008.07.006
11. Colzato, L. S., van den Wildenberg, W. P. M., and Hommel, B. (2008b). Reduced spontaneous eye blink rates in recreational cocaine users: evidence for dopaminergic hypoactivity. PLoS ONE 2:e3461. doi: 10.1371/journal.pone.0003461
12. Colzato, L. S., van den Wildenberg, W. P. M., and Hommel, B. (2013b). The genetic impact (C957T-DRD2) on inhibitory control is magnified by aging. Neuropsychologia 51, 1377-1381. doi: 10.1016/j.neuropsychologia.2013.01.014
13. Colzato, L. S., van den Wildenberg, W. P. M., van der Does, A. J. W., and Hommel, B. (2010). Genetic markers of striatal dopamine predict individual differences in dysfunctional, but not function impulsivity. Neuroscience 170, 782-788. doi: 10.1016/j.neuroscience.2010.07.050
14. Colzato, L. S., van den Wildenberg, W. P. M., van Wouwe, N. C., Pannebakker, M. M., and Hommel, B. (2009). Dopamine and inhibitory action control: evidence from spontaneous eye blink rates. Exp. Brain Res. 196, 467-474. doi: 10.1007/s00221-009-1862-x
15. Colzato, L. S., van Wouwe, N. C., and Hommel, B. (2007a). Feature binding and affect: emotional modulation of visuo-motor integration. Neuropsychologia 45, 440-446. doi: 10.1016/j.neuropsychologia.2006.06.032
16. Colzato, L. S., van Wouwe, N. C., and Hommel, B. (2007b). Spontaneous eyeblink rate predicts the strength of visuomotor binding. Neuropsychologia 45, 2387-2392. doi: 10.1016/j.neuropsychologia.2007.03.004
17. Colzato, L. S., Zmigrod, S., and Hommel, B. (2013c). Dopamine, norepinephrine, and the management of sensorimotor bindings: individual differences in updating of stimulus-response episodes are predicted by DAT1, but not DBH5'-ins/del. Exp. Brain Res. 228, 213-220. doi: 10.1007/s00221-013-3553-x
18. Cools, R. (2006). Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neurosci. Biobehav. Rev. 30, 1-23. doi: 10.1016/j.neubiorev.2005.03.024
19. Cools, R., Frank, M. J., Gibbs, S. E., Miyakawa, A., Jagust, W., and D'Esposito, M. (2009). Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration. J. Neurosci. 29, 1538-1543. doi: 10.1523/JNEUROSCI.4467-08.2009
20. Cools, R., Gibbs, S. E., Miyakawa, A., Jagust, W., and D'Esposito, M. (2008). Working memory capacity predicts dopamine synthesis capacity in the human striatum. J. Neurosci. 28, 1208-1212. doi: 10.1523/JNEUROSCI.4475-07.2008
21. Cuche, J. L., Prinseau, J., Selz, F., Ruget, G., Tual, J. L., Reingeissen, L., et al. (1985). Oral load of tyrosine or L-dopa and plasma levels of free and sulfoconjugated catecholamines in healthy men. Hypertension 7, 81-89. doi: 10.1161/01.HYP.7.1.81
22. Daubner, S. C., Le, T., and Wang, S. Z. (2011). Tyrosine hydroxylase and regulation of dopamine synthesis. Arch. Biochem. Biophys. 508, 1-12. doi: 10.1016/j.abb.2010.12.017
23. Deijen, J. B., and Orlebeke, J. F. (1994). Effect of tyrosine on cognitive function and blood pressure under stress. Brain Res. Bull. 33, 319-323. doi: 10.1016/0361-9230(94)90200-3
24. Deuschel, G., and Goddemeier, C. (1998). Spontaneous and reflex activity of facial muscles in dystonia, Parkinson's disease, and in normal subjects. J. Neurol. Neurosurg. Psychiatry 64, 320-324. doi: 10.1136/jnnp.64.3.320
25. Dreisbach, G., Müller, J., Goschke, T., Strobel, A., Schulze, K., Lesch, K., et al. (2005). Dopamine and cognitive control: the influence of spontaneous eyeblink rate and dopamine gene polymorphisms on perseveration and distractibility. Behav. Neurosci. 119, 483-490. doi: 10.1037/0735-7044.119.2.483
26. Duan, J., Wainwright, M. S., Comeron, J. M., Saitou, N., Sanders, A. R., Gelernter, J., et al. (2003). Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum. Mol. Genet. 12, 205-216. doi: 10.1093/hmg/ddg055
27. Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, D., et al. (2001). Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 98, 6917-6922. doi: 10.1073/pnas.111134598
28. Erixon-Lindroth, N., Farde, L., Wahlin, T. B., Sovago, J., Halldin, C., and Bäckman, L. (2005). The role of the striatal dopamine transporter in cognitive aging. Psychiatry Res. 138, 1-12. doi: 10.1016/j.pscychresns.2004.09.005
29. Freed, W. (1980). Eye-blink rates and platelet monoamine oxidase activity in chronic schizophrenic patients. Biol. Psychiatry 15, 329-332.
30. Gelenberg, A. J., and Gibson, C. J. (1984). Tyrosine for the treatment of depression. Nutr. Health 3, 163-173.
31. Gibson, C. J., and Wurtman, R. J. (1977). Physiological control of brain catechol synthesis by brain tyrosine concentration. Biochem. Pharmacol. 26, 1137-1142. doi: 10.1016/0006-2952(77)90057-0
32. Goldberg, T. E., and Weinberger, D. R. (2004). Genes and the parsing of cognitive processes. Trends Cogn. Sci. 8, 325-335. doi: 10.1016/j.tics.2004.05.011
33. Goldman-Rakic, P. S., Muly, E. C., and Williams, G. V. (2000). D1 receptors in prefrontal cells and circuits. Brain Res. Rev. 31, 295-301. doi: 10.1016/S0165-0173(99)00045-4
34. Growdon, J. H., Melamed, E., Logue, M., Hefti, F., and Wurtman, R. J. (1982). Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease. Life Sci. 30, 827-832.
35. Hirvonen, M. M., Laakso, A., Någren, K., Rinne, J. O., Pohjalainen, T., and Hietala, J. (2009b). C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity. Synapse 63, 907-912. doi: 10.1002/syn.20672
36. Hirvonen, M. M., Lumme, V., Hirvonen, J., Pesonen, U., Någren, K., Vahlberg, T., et al. (2009a). C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 630-636. doi: 10.1016/j.pnpbp.2009.02.021
37. Horiguchi, M., Ohi, K., Hashimoto, R., Hao, Q., Yasuda, Y., Yamamori, H., et al. (2014). Function polymorphism (C-824T) of the tyrosine hydroxylase gene affects IQ in schizophrenia. Psychiatry Clin. Neurosci. 68, 456-462. doi: 10.1111/pcn.12157
38. Hulka, L. M., Wagner, M., Preller, K. H., Jenni, D., and Quednow, B. B. (2013). Blue-yellow color vision impairment and cognitive deficits in occasional and dependent stimulant users. Int. J. Neuropsychopharmacol. 16, 535-547. doi: 10.1017/S1461145712000624
39. Karson, C. N. (1983). Spontaneous eye-blink rates and dopaminergic systems. Brain 106, 643-653. doi: 10.1093/brain/106.3.643
40. Lemoine, P., Robelin, N., Sebert, P., and Mouret, J. (1989). L-tyrosine: a long term treatment of Parkinson's disease. C. R. Acad. Sci. 309, 43-47.
41. Lewis, D., Melchitzky, D., Sesack, S., Whitehead, R., Auh, S., and Sampson, A. (2001). Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization. J. Comp. Neurol. 432, 119-136. doi: 10.1002/cne.1092
42. Li, S.-C., Papenberg, G., Nagel, I. E., Preuschhof, C., Schröder, J., Nietfeld, W., et al. (2013). Aging magnifies the effects of dopamine transporter and D2 receptor genes on backward serial memory. Neurobiol. Aging, 34, 358. doi: 10.1016/j.neurobiolaging.2012.08.001
43. Lindenberger, U., Nagel, I. E., Chicerio, C., Li, S.-C., Heekeren, H. R., and Bäckman, L. (2008). Age-related decline in brain resources modulates genetic effects on cognitive functioning. Front. Neurosci. 2, 234-244. doi: 10.3389/neuro.01.039.2008
44. Mahoney, C. R., Castellani, J., Kramer, F. M., Young, A., and Lieberman, H. R. (2007). Tyrosine supplementation mitigates memory decrements during cold exposure. Physiol. Behav. 92, 575-582. doi: 10.1016/j.physbeh.2007.05.003
45. Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., et al. (2003). Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc. Natl. Acad. Sci. U.S.A. 100, 6186-6191. doi: 10.1073/pnas.0931309100
46. Miyake, A., Friedman, N. P., Emerson, M. J., Witzki, A. H., Howerter, A., and Wager, T. D. (2000). The unity and diversity of executive functions and their contributions to complex "frontal lobe" tasks: a latent variable analysis. Cogn. Psychol. 41, 49-100. doi: 10.1006/cogp.1999.0734
47. Muly, E. C. 3rd. Szigeti, K., and Goldman-Rakic, P. S. (1998). D1 receptor in interneurons of macaque prefrontal cortex: distribution and subcellular localization. J. Neurosci. 18, 10553-10565.
48. Nieoullon, A. (2002). Dopamine and the regulation of cognition and attention. Prog. Neurobiol. 67, 53-83. doi: 10.1016/S0301-0082(02)00011-4
49. Pieri, V., Diederich, N. J., Raman, R., and Goetz, C. G. (2000). Decreased color discrimination and contrast sensitivity in Parkinson's disease. J. Neurol. Sci. 172, 7-11. doi: 10.1016/S0022-510X(99)00204-X
50. Rao, F., Zhang, L., Wessel, J., Zhang, K., Wen, G., Kennedy, B. P., et al. (2007). Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo. Circulation 116, 993-1006. doi: 10.1161/CIRCULATIONAHA.106.682302
51. Roy, A., Roy, M., Berman, J., and Gonzalez, B. (2003). Blue cone electroretinogram amplitudes are related to dopamine function in cocaine-dependent patients. Psychiatry Res. 117, 191-195. doi: 10.1016/S0165-1781(02)00323-2
52. Shumay, E., Chen, J., Fowler, J. S., and Volkow, N. D. (2011). Genotype and ancestry modulate brain's DAT availability in healthy humans. PLoS ONE 6:e22754. doi: 10.1371/journal.pone.0022754
53. Shurtleff, D., Thomas, J. R., Schrot, J., Kowalski, K., and Harford, R. (1994). Tyrosine reverses a cold-induced working memory deficit in humans. Pharmacol. Biochem. Behav. 47, 935-941. doi: 10.1016/0091-3057(94)90299-2
54. Tannock, R., Banaschewski, T., and Gold, D. (2006). Color naming deficits and attention-deficit/hyperactivity disorder: a retinal dopaminergic hypothesis. Behav. Brain Funct. 2:4. doi: 10.1186/1744-9081-2-4
55. Thomas, J. R., Lockwood, P. A., Singh, A., and Deuster, P. A. (1999). Tyrosine improves working memory in a multitasking environment. Pharmacol. Biochem. Behav. 64, 495-500. doi: 10.1016/S0091-3057(99)00094-5
56. van de Giessen, E., de Win, M. M. L., Tanck, M. W. T., van den Brink, W., Baas, F., and Booij, J. (2009). Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J. Nucl. Med. 50, 45-52. doi: 10.2967/jnumed.108.053652
57. van Spronsen, F. J., van Dijk, T., Smit, G. P. A., van Rijn, M., Reijngoud, D. J., Berger, R., et al. (1996). Large daily fluctuations in plasma tyrosine in treated patients with phenylketonuria. Am. J. Clin. Nutr. 64, 916-921.
58. Volkow, N. D., Fowler, J. S., Wang, G. J., Baler, R., and Telang, F. (2009). Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 56, 3-8. doi: 10.1016/j.neuropharm.2008.05.022
59. Volkow, N. D., Wang, G. J., Fowler, J. S., Ding, Y. S., Gur, R. C., Gatley, J., et al. (1998). Parallel loss of presynaptic and postsynaptic dopamine makers in normal aging. Ann. Neurol. 44, 143-147.
60. Witkovsky, P. (2004). Dopamine and retinal function. Doc. Ophthalmol. 108, 17-40. doi: 10.1023/B:DOOP.0000019487.88486.0a
61. Wood, D. R., Reimherr, F. W., and Wender, P. H. (1985). Amino acid precursors for the treatment of attention deficit disorder, residual type. Psychopharmacol. Bull. 21, 146-149.